Skip to main content
SpringerLink
Log in

Detection and isolation of MUC1 mucin from larynx squamous cell carcinoma

  • Article
  • Published:
Pathology & Oncology Research

Abstract

The progression from uncontrolled cell proliferation to invasion and metastasis of epithelial tumors is partially understood. Alteration of epithelial mucin expression have been described in different malignant localizations but only few attempts have been made to identify mucin expression in malignant laryngeal tumors. In the present report, results are shown of studies on the expression of mucins and carbohydrate related antigens in laryngeal cancer and on the isolation of MUC1 mucin from this tumor tissue. Malignant laryngeal specimens were processed for immunohistochemical analysis and for extranuclear membrane fractions (ENM) which were obtained by ultracentrifugation. Subsequently, ENM samples were centrifuged in density-gradient; the analysis of fractions was performed by means of SDS-PAGE and Western-blotting. The panel of monoclonal antibodies (MAbs) included anti MUC1 mucin, anti Lewis x, anti sialyl Lewis x, anti Lewis y, anti MUC-5B, anti oral mucin (gp230), anti Tn hapten, anti p53 and anti cytokeratins. By immunohistochemistry, it was possible to detect MUC1 mucin, Lewis x and Lewis y showing strong reactions while sialy1-Lewis x and Tn antigen only reacted weakly in a few cells; cytokeratins were detected in all samples. In ENM derived fractions obtained by CsC1 centrifugation, MUC1 was demonstrated by Western blotting. Conclusions: (1) laryngeal cancer antigenic expression comprises mostly MUC1 mucin, Lewis x, Lewis y as well as Tn antigen and (2) the methodology here employed is useful to isolate MUC1 from tumor samples.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aksoy N, Corfield AP, Paraskeva C, et at Human intestinal mucin MUC2 inin vitro two adenoma-carcinoma sequences originated from a single benign colonic adenoma cell line:In vitro evidence for the neotransformation. 5th International Workshop on Carcinoma Associated Mucins, Cambridge, UK, 1998.

  2. Barnd DL, Lan M, Metzgar R, et al: Specific, MHC-unrestricted recognition of tumor associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA; 86:7159–7163, 1989.

    Article  PubMed  CAS  Google Scholar 

  3. Bradford CR: Predictive factors in head and neck cancer. Hemotol Oncol Clin North Am 13:777–785, 1999.

    Article  CAS  Google Scholar 

  4. Brown A, Feizil T, Gooi HC: A monoclonal antibody against human colonie adenoma recognizes a difucosylated type-2 blood group chains. Biosci Rep 3:163–169, 1983.

    Article  PubMed  CAS  Google Scholar 

  5. Chiesa F, Mauri S, Tradati N, et al: Surfing prognostic factors in head and neck cancer at the Millennium. Oral Oncol 35:590–596, 1999.

    Article  PubMed  CAS  Google Scholar 

  6. Creeth JM, Ramakrishnan Bhaskar K, et al: The separation and characterization of bronchial glycoproteins by density-gradient methods. Biochem J 167:557–569, 1977.

    PubMed  CAS  Google Scholar 

  7. Croce MV, Price MR, Segal-Eiras A: Expression of monoclonal antibody-defined antigens in fractions isolated from human breast carcinoma and patients’ serum. Cancer Immunol Immunother; 40:132–137, 1995.

    Article  PubMed  CAS  Google Scholar 

  8. Croce MV, Colussi AG, Price M, et al: A Immunohistopathological characterization of spontaneous metastases in a human lung mucoepidermoid adenocarcinoma (HLMC) xenograft. Pathol Oncol Res 4:259–266, 1998.

    Article  PubMed  CAS  Google Scholar 

  9. Dolcetti R, Doglioni C, Maestro R, et al: A p53 over expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications. Int J Cancer 52:178–182, 1992.

    Article  PubMed  CAS  Google Scholar 

  10. Federici MF, Kudryashov, Saigo PE, et al: Selection of carbohydrate antigens in human epithelial ovarian cancers for immunotherapy: serous and mucinous tumors exhibit distinctive patterns of expression. Int J Cancer 81:193–198, 1999.

    Article  PubMed  CAS  Google Scholar 

  11. Feickert HJ, Anger BR, Cordon-Cardo, et al: Cell-surface antigens of human lung tumors detected by mouse monoclonal antibodies: definition of blood-groupand non-blood-grouprelated antigenic systems. Int J Cancer: 46:1007–1013, 1990.

    Article  PubMed  CAS  Google Scholar 

  12. Gendler SJ, Taylor-Papadimitriou J, Duhig T, et al: A highly immunogenic region of human polymorphic mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 263:12820–12823, 1988.

    PubMed  CAS  Google Scholar 

  13. Gendler SJ, Spicer AP: Epithelial mucin genes: Annu Rev Physiol 57:607–634, 1995.

    PubMed  CAS  Google Scholar 

  14. Hakomori S, Nudelman E, Levery SB, et al: Novel fucolipids accumulating in human adenocarcinoma: I. Glycolipids with dior trifucosylated type 2 chain. J Biol Chem 259:4672–4680, 1984.

    PubMed  CAS  Google Scholar 

  15. Hanai N, Shitara K, Yoshida H: Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung. Cancer Res 46:4438–4443, 1986.

    PubMed  CAS  Google Scholar 

  16. Hilkens J, Ligtenberg JL, Vos HL, et al: Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci 17:359–363, 1992.

    Article  PubMed  CAS  Google Scholar 

  17. Hurlimann J, Saraga EP. Expression of p53 protein in gastric carcinomas. Am J Surg Pathol 18:1247–1253, 1994.

    Article  PubMed  CAS  Google Scholar 

  18. International Union Against Cancer (UICC) Classification of Malignant Tumors. Ed. L.H. Sobin and Ch. Wittekind, 5th edition, New York, 1997.

  19. Ioannides CG, Fisk B, Jerome KR, Irimura T: Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J Immunol 151: 3693–3703, 1993.

    PubMed  CAS  Google Scholar 

  20. Itoh T Yonezawa S, Nemoto M, et al Expression of mucin antigen and Lewis x-related antigens in carcinomas and dysplasia of the pharynx and larynx. Pathol Int 46: 646–655, 1996.

    Article  PubMed  CAS  Google Scholar 

  21. Jerome KR, Barnd DL, Bendt KM: Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 5:2908–2916, 1991.

    Google Scholar 

  22. Johnson NW: Orofacial neoplasms: global epidemiology, risk factors and recommendations for research. Int Dental J 41:365, 1991.

    CAS  Google Scholar 

  23. Kotera Y, Darrell Fontenot J, Pecher G, et al: Humoral immunity against a tandem repeat epitope of human mucin MUC1 in sera from breast, pancreatic and colon cancer patients. Cancer Res 54:2856–2860, 1994.

    PubMed  CAS  Google Scholar 

  24. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227:680–681, 1980.

    Article  Google Scholar 

  25. McDonald LA, Walker DM, Gibbins JR: Cervical lymph node involvement in head and neck cancer detectable as expression of a spliced transcript of type II keratin K5. Oral Oncol 34:276–283, 1998.

    PubMed  CAS  Google Scholar 

  26. Wees M, Homann N, Discher H, Andl T, et al: Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patient: a possible molecular basis for the development of multiple tumors. Cancer Res 53:4189–4196, 1993.

    Google Scholar 

  27. Nielsen PA, Mandel U, Therkildsen MH, et al: Differential expression of human high-molecular-weight salivary mucin (MG1) and low-molecular-weight salivary mucin (MG2). J.Dent Res 75:1820–1826, 1996.

    Article  PubMed  CAS  Google Scholar 

  28. Nielsen PA, Mandel U, Therkildsen MH, et al: Loss of a novel mucin-like epithelial glycoprotein in oral and cervical squamous cell carcinoma. Cancer Res 57:634–640, 1997.

    PubMed  CAS  Google Scholar 

  29. Nylander K, Stenling R, Gustafsson H, et al:p53 expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer 75:87–93, 1994.

    Article  Google Scholar 

  30. Pancino GF, Osinaga E, Vorauher W et al: Production of a monoclonal antibody as immunohistochemical marker on paraffin embedded tissues using a new immunization method. Hybridoma 9:389–395, 1990.

    Article  PubMed  CAS  Google Scholar 

  31. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–599, 1993.

    Article  PubMed  CAS  Google Scholar 

  32. Price MR, Edwards S, Owainati A, et al: Multiple epitopes on a human breast carcinoma associated antigen. Int J Cancer 36:567–574, 1985.

    Article  PubMed  CAS  Google Scholar 

  33. Price MR, Pugh J, Hudecz F, et al: Immunological and structural features of the protein core of human polymorphic epithelial mucin. Mol Immunol 27:795–801, 1990.

    Article  PubMed  CAS  Google Scholar 

  34. Quinlan DC, Davidson AG, Summers CL, et al: Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 52:4828–4831, 1992.

    PubMed  CAS  Google Scholar 

  35. Ravindranath NH, Nishimoto K, Chu K, et al: Density of cell surface expression of sialyl Lewis antigens and complement restriction factors in oral squamous cell carcinoma. Proc Am Ass for Cancer Res 40:357 1999.

    Google Scholar 

  36. Regimbald LH, Pilarski LM, Longenecker BM: The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. Cancer Res 56:4244–4249, 1996.

    PubMed  CAS  Google Scholar 

  37. Rowley H, Poland NJ, Helliwell TR, et al P53 protein expression in tumors from head and subsites, larynx and hypopharynx and differences in relationship to survival. Clin Otolaryngol 23:57–62, 1998.

    Article  PubMed  CAS  Google Scholar 

  38. Rughetti A, Turchi V, Apollonj Ghetti C: Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res 53:2457–2459, 1993.

    PubMed  CAS  Google Scholar 

  39. Suo Z, Holm R, Nesland JM: Squamous cell carcinomas. An immunohistochemical study of cytokeratins and involucrin in primary and metastatic tumors. Histopathol 23:45–54, 1993.

    Article  CAS  Google Scholar 

  40. Svitacheva N, Davies JR, Lesuffleur T: Characterization of mucins produced by human HT29-MTX cell line. 5th International Workshop on Carcinoma Associated Mucins Cambridge, UK, 1998.

  41. Takada A, Ohmori K, Yoneda T: Contribution of carbohydrate antigens sialyl Lewis a and sialyl Lewis x to adhesion of human cancer cells to vascular endothelium. Cancer Res 53:354–361, 1993.

    PubMed  CAS  Google Scholar 

  42. Taylor KL, Mall AS, Barnard RA: Immunohistochemical detection of gastric mucin in normal and disease states. Oncol Res, 10:465–473, 1998.

    PubMed  CAS  Google Scholar 

  43. Taylor-Papadimitriou J, Peterson J, Arklie J: Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer 28:17–21, 1981.

    Article  PubMed  CAS  Google Scholar 

  44. Taylor-Papadimitriou J, Finn O: Biology, biochemistry and immunology of carcinoma associated mucins. Immunol Today 18:105–107, 1997.

    Article  PubMed  CAS  Google Scholar 

  45. Thornton DJ, Devine PL, Hanski Ch, et al: Identification of two major populations of mucins in respiratory secretions. Am J Respir Crit Care Med 150:823–832, 1994.

    PubMed  CAS  Google Scholar 

  46. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: procedures and some applications. Proc Natl Acad Sci USA 76:4350–4354, 1979

    Article  PubMed  CAS  Google Scholar 

  47. Whitehouse C, Burchell J, Gschmeissner S: A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans Golgi apparatus inhibits the development of core-2-based O-glycans. J Cell Biol 137:1229–1241, 1997.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Research Laboratory, School of Pharmaceutical Sciences, University of Nottingham, UK

    Mike R. Price

  2. CINIBA, Universidad Nacional La Plata, Calle 60 y 120, Argentina

    María V. Croce & Amada Segal-Eiras

Authors
  1. María V. Croce
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mike R. Price
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amada Segal-Eiras
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amada Segal-Eiras.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Croce, M.V., Price, M.R. & Segal-Eiras, A. Detection and isolation of MUC1 mucin from larynx squamous cell carcinoma. Pathol. Oncol. Res. 6, 93–99 (2000). https://doi.org/10.1007/BF03032356

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03032356

Keywords

Search

Navigation